125 related articles for article (PubMed ID: 8999923)
21. Two chimeric receptors of epidermal growth factor receptor and c-Ros that differ in their transmembrane domains have opposite effects on cell growth.
Xiong Q; Chan JL; Zong CS; Wang LH
Mol Cell Biol; 1996 Apr; 16(4):1509-18. PubMed ID: 8657124
[TBL] [Abstract][Full Text] [Related]
22. Activation of the Axl receptor tyrosine kinase induces mitogenesis and transformation in 32D cells.
McCloskey P; Pierce J; Koski RA; Varnum B; Liu ET
Cell Growth Differ; 1994 Oct; 5(10):1105-17. PubMed ID: 7848912
[TBL] [Abstract][Full Text] [Related]
23. Kinetics of binding, endocytosis, and recycling of EGF receptor mutants.
Felder S; LaVin J; Ullrich A; Schlessinger J
J Cell Biol; 1992 Apr; 117(1):203-12. PubMed ID: 1556153
[TBL] [Abstract][Full Text] [Related]
24. An oncogenic point mutation confers high affinity ligand binding to the neu receptor. Implications for the generation of site heterogeneity.
Ben-Levy R; Peles E; Goldman-Michael R; Yarden Y
J Biol Chem; 1992 Aug; 267(24):17304-13. PubMed ID: 1355090
[TBL] [Abstract][Full Text] [Related]
25. Protein tyrosine phosphorylation induced by epidermal growth factor and insulin-like growth factor-I in a rat clonal dental pulp-cell line.
Kawase T; Orikasa M; Ogata S; Burns DM
Arch Oral Biol; 1995 Oct; 40(10):921-9. PubMed ID: 8526802
[TBL] [Abstract][Full Text] [Related]
26. Ligand-induced stimulation of epidermal growth factor receptor mutants with altered transmembrane regions.
Kashles O; Szapary D; Bellot F; Ullrich A; Schlessinger J; Schmidt A
Proc Natl Acad Sci U S A; 1988 Dec; 85(24):9567-71. PubMed ID: 3264402
[TBL] [Abstract][Full Text] [Related]
27. Release of a phorbol ester-induced mitogenic block by mutation at Thr-654 of the epidermal growth factor receptor.
Livneh E; Dull TJ; Berent E; Prywes R; Ullrich A; Schlessinger J
Mol Cell Biol; 1988 Jun; 8(6):2302-8. PubMed ID: 3136317
[TBL] [Abstract][Full Text] [Related]
28. Multisite phosphorylation of the epidermal growth factor receptor. Use of site-directed mutagenesis to examine the role of serine/threonine phosphorylation.
Countaway JL; McQuilkin P; Gironès N; Davis RJ
J Biol Chem; 1990 Feb; 265(6):3407-16. PubMed ID: 2105948
[TBL] [Abstract][Full Text] [Related]
29. Biological activities of EGF-receptor mutants with individually altered autophosphorylation sites.
Honegger A; Dull TJ; Bellot F; Van Obberghen E; Szapary D; Schmidt A; Ullrich A; Schlessinger J
EMBO J; 1988 Oct; 7(10):3045-52. PubMed ID: 3263271
[TBL] [Abstract][Full Text] [Related]
30. Domain deletion in the extracellular portion of the EGF-receptor reduces ligand binding and impairs cell surface expression.
Lax I; Bellot F; Honegger AM; Schmidt A; Ullrich A; Givol D; Schlessinger J
Cell Regul; 1990 Jan; 1(2):173-88. PubMed ID: 2100196
[TBL] [Abstract][Full Text] [Related]
31. Independent mechanisms account for the regulation by protein kinase C of the epidermal growth factor receptor affinity and tyrosine-protein kinase activity.
Davis RJ
J Biol Chem; 1988 Jul; 263(19):9462-9. PubMed ID: 3379075
[TBL] [Abstract][Full Text] [Related]
32. Constitutive phosphorylation of eps8 in tumor cell lines: relevance to malignant transformation.
Matoskova B; Wong WT; Salcini AE; Pelicci PG; Di Fiore PP
Mol Cell Biol; 1995 Jul; 15(7):3805-12. PubMed ID: 7791787
[TBL] [Abstract][Full Text] [Related]
33. Transforming growth factor beta 1 inhibits epidermal growth factor receptor endocytosis and down-regulation in cultured fetal rat hepatocytes.
Baskin G; Schenker S; Frosto T; Henderson G
J Biol Chem; 1991 Jul; 266(20):13238-42. PubMed ID: 1649185
[TBL] [Abstract][Full Text] [Related]
34. The carboxyl terminus of epidermal growth factor receptor/erbB-2 chimerae is internalization impaired.
Sorkin A; Di Fiore PP; Carpenter G
Oncogene; 1993 Nov; 8(11):3021-8. PubMed ID: 8105439
[TBL] [Abstract][Full Text] [Related]
35. A mutant epidermal growth factor receptor with defective protein tyrosine kinase is unable to stimulate proto-oncogene expression and DNA synthesis.
Honegger AM; Szapary D; Schmidt A; Lyall R; Van Obberghen E; Dull TJ; Ullrich A; Schlessinger J
Mol Cell Biol; 1987 Dec; 7(12):4568-71. PubMed ID: 3501826
[TBL] [Abstract][Full Text] [Related]
36. Protein kinase C mediates short- and long-term effects on receptor tyrosine kinases. Regulation of tyrosine phosphorylation and degradation.
Seedorf K; Sherman M; Ullrich A
Ann N Y Acad Sci; 1995 Sep; 766():459-62. PubMed ID: 7486691
[No Abstract] [Full Text] [Related]
37. Cross talk among tyrosine kinase receptors in PC12 cells: desensitization of mitogenic epidermal growth factor receptors by the neurotrophic factors, nerve growth factor and basic fibroblast growth factor.
Mothe I; Ballotti R; Tartare S; Kowalski-Chauvel A; Van Obberghen E
Mol Biol Cell; 1993 Jul; 4(7):737-46. PubMed ID: 8400459
[TBL] [Abstract][Full Text] [Related]
38. Activation of insulin-epidermal growth factor (EGF) receptor chimerae regulates EGF receptor binding affinity.
Tartare S; Ballotti R; Lammers R; Filloux C; Chauvel A; Schlessinger J; Ullrich A; Van Obberghen E
J Cell Biol; 1992 Feb; 116(3):627-33. PubMed ID: 1309816
[TBL] [Abstract][Full Text] [Related]
39. Expression of human tyrosine kinase-negative epidermal growth factor receptor amplifies signaling through endogenous murine epidermal growth factor receptor.
Hack N; Sue-A-Quan A; Mills GB; Skorecki KL
J Biol Chem; 1993 Dec; 268(35):26441-6. PubMed ID: 8253771
[TBL] [Abstract][Full Text] [Related]
40. Internalization and down-regulation of the human epidermal growth factor receptor are regulated by the carboxyl-terminal tyrosines.
Helin K; Beguinot L
J Biol Chem; 1991 May; 266(13):8363-8. PubMed ID: 2022652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
